-
US jury finds Elon Musk misled Twitter shareholders
-
Gauff rallies to avance at Miami Open
-
WNBA, players union confirm agreement on 'groundbreaking' labor deal
-
Carrick 'baffled' by inconsistent penalty calls as Man Utd held
-
Trump says considering 'winding down' Iran war but rules out ceasefire
-
Trump mulls 'winding down' Iran war
-
Man Utd held by Bournemouth after Maguire sees red
-
Lens go top of Ligue 1 with handsome Angers win
-
Leipzig pummel Hoffenheim to climb to third
-
Quinn ousts 11th seed Ruud at rain-hit Miami Open
-
Rap group Kneecap says crisis-hit Cuba being 'strangled'
-
Anthony, Jackson nail US double at world indoors
-
Zarco seizes his moment as rain disrupts Brazil MotoGP practice
-
Chuck Norris, roundhouse-kicking action star, dead at 86
-
US newcomer Anthony crowned world indoor sprint king
-
Trump rules out Iran truce as more Marines head to Middle East
-
Costa Rican ex-security minister extradited to US for drug trafficking
-
Trump slams NATO 'cowards' as more Marines head to Middle East
-
Gulf's decades-long strategy of sporting investment rocked by Mideast war
-
Souped-up VPNs play 'cat and mouse' game with Iran censors
-
Attacked Russian tanker drifting toward Libya: Italian authorities
-
Coroner 'not satisfied' boxer Hatton intended to take own life
-
Stocks drop, as oil rises as Mideast war persists
-
Vanishing glacier on Germany's highest peak prompts ski lift demolition
-
Chuck Norris, roundhouse-kicking action star, dead at 86: family
-
Supreme leader says Iran dealt enemies 'dizzying blow'
-
Audi team principal Wheatley in shock exit after two races
-
Spurs boss Tudor hopes for 'nice surprises' in relegation fight
-
Arsenal must prove they are winners in League Cup final, says Arteta
-
Record-breaking heat wave grips western US
-
Liverpool showdown brings back 'beautiful memories' for PSG coach Luis Enrique
-
IRA bomb victims drop civil court claim against Gerry Adams
-
Ntamack returns for Toulouse to face France rival Jalibert
-
Trump calls NATO allies 'cowards' over Iran
-
French jihadist jailed for life for Islamic State crimes against Yazidis
-
Chuck Norris, action man who inspired endless memes, dead at 86: family
-
Action movie star Chuck Norris has died: family statement
-
England stars have 'last chance' to earn World Cup spots: Tuchel
-
League Cup final a 'big moment' for Man City, says Guardiola
-
Injured Ronaldo misses Portugal World Cup friendlies
-
Liverpool condemn 'cowardly' racist abuse of Konate
-
Far from war, global fuel frustrations mount
-
German auto exports to China plunged a third in 2025: study
-
Coach Valverde to leave Bilbao at end of season
-
'Decimated'? The Iranian leaders killed in Israeli-US war
-
Mistral chief calls for European AI levy to pay creatives
-
Liverpool suffer Salah blow in chase for Champions League
-
Mahuchikh soars to world indoor high jump gold, Hodgkinson cruises
-
Spain include Joan Garcia as one of four new call-ups
-
Salah ruled out of Liverpool's Brighton clash
Featured
Last news
Who Does the Best Liposuction in Las Vegas?
The Best Liposuction in Las Vegas is by Dr. Ahmed
CASI Pharmaceuticals Announces Results from CID-103 Immune Thrombocytopenia Study at the 67th American Society of Hematology (ASH) Annual Meeting
SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 8, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company developing CID-103, a potentially best-in-class, anti-CD38 monoclonal antibody, for patients with organ transplant rejection and autoimmune diseases, today announced data presented from its Phase 1 open-label study of CID-103 in adult patients with immune thrombocytopenia (ITP) at the 67th American Society of Hematology Annual Meeting and Exposition on December 7, 2025, in Orlando, Florida.
Armanino Foods Announces Fourth Quarter 2025 Dividend
Quarterly Cash Dividend of $0.05 per Share to be Paid to Shareholders of Record as of January 16, 2026
Survey Reveals Cautious Optimism in PIPE Market as Investors Eye Technology, Healthcare, and Cleantech in 2026
NEW YORK, NY / ACCESS Newswire / December 8, 2025 / DealFlow Events today released the results of its PIPE Market Trends & Sentiment Survey, conducted during the 2025 PIPEs Conference. The findings point to measured but growing optimism in the market, with a majority of respondents describing current PIPE conditions as at least "somewhat healthy" and expecting transaction activity to increase over the next year.
Wellgistics Health Announces Launch of Diabetes Drug Brenzavvy(R) to Wellgistics Pharmacy Network
Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom are uninsured and underinsured and whose out-of-pocket costs exceed Brenzavvy's cash priceProprietary EinsteinRx™ artificial intelligence pharmacy platform empowers the 6,500+ pharmacies in the Wellgistics Pharmacy Network to educate patients and providers on the advantages of Brenzavvy vs. Jardiance® and other SGLT-2 inhibitorsReduced out-of-pocket costs for patients, paired with a patient-education revenue opportunity for pharmacists, are designed to support broader market access to Brenzavvy and enhance the overall care experienceLaunch establishes a new model for next-generation reformulated drugs that offer patient-specific product advantages compared with entrenched market leaders
Avant Brands Fully Repays $9.5M Secured Convertible Debenture
KELOWNA, BC / ACCESS Newswire / December 8, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, today announced the full repayment of its $9.5 million amended and restated convertible debenture (the "A&R Debenture"). The final payment was completed in November 2025, retiring in full the obligation originally issued in connection with the 2023 acquisition of 3PL Ventures Inc.
Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz
All closing requirements satisfied following announcement of a non-binding term-sheet agreement in July and signing of contract in NovemberAgreement includes approximately US$ 350 m in cash for Just - Evotec Biologics manufacturing site in Toulouse and upfront technology license fees to Evotec's continuous manufacturing platformIn addition, Evotec eligible for license fees, and development revenues including success-based milestones adding up to more than US$ 300 m over the coming years,replacing existing contractual commitmentsTransaction covering royalties on a portfolio ofup to ten biosimilars in technical and early development targetingmore than US$ 90 bn of originator net salesSale immediately earnings accretive, improving Evotec's short, mid and long-term revenue mix, profit margins, and capital efficiency
100 kidnapped Nigerian schoolchildren released: UN source, presidency
Nigerian authorities have secured the release of 100 kidnapped schoolchildren taken by gunmen from a Catholic school last month, a UN source and local media said Sunday, though the fate of the 165 students and staff thought to remain in captivity remains unclear.
Renowned British photographer Martin Parr dies aged 73
Celebrated British documentary photographer Martin Parr has died at his home in the western English city Bristol, his foundation announced on Sunday. He was 73.
India nightclub fire kills 25 in Goa
A fire that ripped through an Indian nightclub in the popular tourist resort region of Goa killed 25 people, the state's chief minister said Sunday.
India nightclub fire kills 23 in Goa
A fire at a nightclub in the west Indian state of Goa has killed at least 23 people, Chief Minister Pramod Sawant and other officials said early Sunday.
MSP Recovery, Inc. Announces Conclusion of SEC Investigation: No Intention to Recommend Enforcement Action Against the Company, its CEO, John H. Ruiz, or its Officers
MIAMI, FLORIDA / ACCESS Newswire / December 7, 2025 / MSP Recovery, Inc. (NASDAQ:MSPR) (the "Company"), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, announces that the staff of the U.S. Securities and Exchange Commission ("SEC") has informed the Company that it has concluded its investigation relating to MSP Recovery, Inc., and does not intend to recommend enforcement action to the Commission against the Company, its CEO, John H. Ruiz, or its officers.
Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science
The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have access to controlled substances for legitimate medical use.Today, the evidence shows the opposite: DEA officials laundering cartel money, DEA lawyers defending unconstitutional judicial processes, DEA executives cycling into industry roles they once regulated and DEA policies obstructing legitimate FDA authorized medical research.
Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering
VANCOUVER, BC / ACCESS Newswire / December 7, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has engaged a U.S. investment bank to serve as its capital markets advisor in connection with the Company's intention to pursue a potential cross-listing of its common shares on the Nasdaq Stock Market LLC ("Nasdaq" or the "Exchange") and to evaluate and structure a potential concurrent equity financing. The structure and terms of the contemplated financing have not yet been finalized.
Hundreds in Tunisia protest against government
Hundreds of people demonstrated on Saturday in the Tunisian capital against the government under the slogan "opposition is not a crime", calling for the release of jailed activists.
New to The Street Broadcasts Tonight on Bloomberg at 6:30 PM EST Featuring Roadzen, BioVie, and TY J Young Wealth
Tonight's show is sponsored by commercials from Laser Photonics, DataVault, Aeries Technology, Sustainable Green Team, PetVivo, and Synergy CHC
AMEEREX Signs MOU to Acquire 45.6 million-Ounce Silver-Gold Project in Nevada, Expanding Its North American Precious-Metals Portfolio
ATLANTA, GA AND DOHA, QATAR / ACCESS Newswire / December 6, 2025 / Ameerex Corporation (OTC:HIRU) ("Ameerex" or the "Company"), a natural-resources group owned and managed by high-profile Qatari investors, announces that it has signed a Memorandum of Understanding (MOU) to acquire a 100% interest in the Corcoran Canyon Silver-Gold Project in Nye County, Nevada.
Shinoda Dental Named Official Distributor of VHF Milling Machines, Strengthening Its Position in Digital Dentistry
Authorized distribution partnership brings VHF's industry-leading milling technology to Shinoda Dental's global customers.
Witness in South Africa justice-system crimes probe shot dead
A witness in a high-profile inquiry into crime and corruption in South Africa's justice system was gunned down late on Friday, just weeks after implicating a municipal police chief, investigators said.
10 university students die in Peru restaurant fire
Ten university students died and three were injured in a restaurant fire in southeastern Peru as they gathered for a birthday celebration, police said Friday.
Migration and crime fears loom over Chile's presidential runoff
Crime and immigration are the issues dominating Chile's presidential election runoff -- nowhere more so than in the northern border city of Arica, where residents say fear has replaced the calm they once knew.
French officer charged after police fracture woman's skull
A policeman has been charged with aggravated assault seven years after a young woman was beaten by more than a dozen officers at a demonstration in southern France, prosecutors said on Friday.
Volcanic eruptions may have brought Black Death to Europe
Previously unknown volcanic eruptions may have kicked off an unlikely series of events that brought the Black Death -- the most devastating pandemic in human history -- to the shores of mediaeval Europe, new research has revealed.
11 million flock to Notre-Dame in year since rising from devastating fire
A year after reopening to the public, Notre-Dame cathedral has drawn more than 11 million visitors, flocking to admire its restored pale stone and minimalist furnishings after the 2019 blaze that devastated the Paris landmark.
Sri Lanka issues fresh landslide warnings as death toll hits 607
Heavy rains triggered fresh landslide warnings in Sri Lanka’s worst-affected central hills on Friday, as the death toll from last week’s Cyclone Ditwah jumped to 607.
EU hits X with 120-mn-euro fine, risking Trump ire
The European Union hit Elon Musk's X with a 120-million-euro ($140-million) fine Friday for breaking its digital rules, in a move that risks a fresh clash with US President Donald Trump's administration.
Survivors pick up pieces in flood-hit Indonesia as more rain predicted
Survivors in Indonesia were piecing back shattered lives Friday after devastating floods killed more than 1,500 people across four countries, with fears of fresh misery as more rain looms.
After 15 years, Dutch anti-blackface group declares victory
Cherished Christmas tradition for some, profoundly insulting for others, the Dutch character "Black Pete", a servant who helps Santa Claus distribute presents, has divided opinion in The Netherlands for decades.
No yolk: police 'recover' Faberge egg swallowed by thief
New Zealand police have recovered a diamond-encrusted green Faberge egg after keeping a six-day watch over the thief accused of swallowing it.
Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Maxim Group LLC is acting as the exclusive Financial Advisor for the transaction
Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement
ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary exosome-based delivery systems, today announced the highly anticipated market launch of its flagship nutraceutical, Maxasome™. Derived exclusively from 100% pure Exosome-Like Nanoparticles (ELNs) extracted from the high-value Yellow Oyster Mushroom (Pleurotus citrinopileatus), Maxasome™ is an unprecedented, all-natural, multi-modal cytoprotective agent designed to deliver unparalleled cellular defense and extend health span.
Medical Care Technologies Inc. (OTC Pink:MDCE) Closes Reg A - Dilution Ends, Growth Phase Begins
MESA, ARIZONA / ACCESS Newswire / December 5, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) is pleased to announce that its Regulation A Tier 1 Offering will formally conclude on December 6, 2025, marking a major milestone in the Company's corporate transition and strengthening its capital structure.